Pfizer's Albert Bourla: 'Blockbuster' drug could make huge difference in cancer fight
Pfizer CEO Albert Bourla discusses the pharma company's next big drug after its COVID vaccine on 'The Claman Countdown.'
Illumina's Francis deSouza touts Grail acquisition amid Carl Icahn proxy fight
Illumina CEO Francis deSouza discusses how the biotech company's purchase of cancer test developer Grail put him in the crosshairs of regulators and activist investor Carl Icahn on 'The Claman Countdown.'
What Is Ozempic and why is it such a big deal right now?
Demand for medications including Ozempic, for weight loss use, led to shortages that sometimes deprived people with diabetes of their prescription refills.
NY considers state-wide tobacco ban, convenient store businesses at risk
FOX Business' Madison Alworth reports from New York City, where convenient stores and smoke shops could soon be prohibited from selling tobacco products.
J&J consumer-health IPO process to kick off key test for moribund new-issue market
J&J’s consumer business makes Tylenol; Band-Aids and other wound-care products; baby-care products such as Johnson’s Baby Shampoo; and skin-care offerings such as Aveeno and Neutrogena.
Jeff 'The 420 Chef' Danzer reinvents the cannabis consumption experience
'The 420 Chef' Jeff Danzer discusses his cannabis-infused cuisine on 'Varney & Co.'
AI is now a part of society, sent the business world into a frenzy: Jay Jacobs
BlackRock U.S. head of thematic and active ETFs Jay Jacobs provides his macro investment picture, telling 'The Claman Countdown' 2023 will go down as the year A.I. exploded onto the scene.
Seeing more weight-loss drug ads? Here's why
Telehealth company Ro promoting obesity care and the highly sought-after drug Wegovy, which has gained widespread attention due to use by celebrities and other public figures.
Former Outcome Health executives found guilty of fraud
A federal jury convicted three former executives of the once-high-flying startup Outcome Health on charges they ran a billion-dollar scheme that defrauded customers.
Colorado high school cancels classes after teacher dies of suspected bacterial meningitis
The Cherry Creek School District warned the community that Eaglecrest High School will be closed Wednesday and all activities and sports will be canceled out of an abundance of caution following the death of teacher Maddie Schmidt.
Medicare beneficiaries would need more than $300,000 for healthcare costs in retirement: EBRI
Medicare beneficiaries in retirement would need to have saved anywhere from $96,000 to $383,000 to cover most of their healthcare needs, according to EBRI. The organization found that in general, Medicare Advantage enrollees have lower savings targets. But these private industry plans have their pros and cons.
Moderna's flu shot faces setback, shares fall
Moderna shares are down Tuesday on news that the biotech's potential flu vaccine will need further review to determine its efficacy against influenza.
Zipline unveils autonomous drones to revolutionize the delivery industry
Zipline CEO Keller Rinaudo Cliffton discusses his company's plan to disrupt the delivery space with a fast and precise autonomous system on 'The Claman Countdown.'
WHO reversing its position on COVID vaccines makes a lot of sense: Dr. Bob Lahita
St. Joseph Health Institute Director Dr. Bob Lahita reacts to the World Health Organization saying healthy kids and teens no longer need a COVID vaccine on 'Varney & Co.'
Lawmakers warn of drug shortages
FOX Business correspondent Lydia Hu has the latest on the pharmaceutical issues on 'Varney & Co.'
TikTok can harm your teen's mental health: Dr. Marc Siegel
Fox News medical contributor Dr. Marc Siegel discusses the dangers of receiving medical advice from social media platforms on 'Varney & Co.'
Deadly fungus and companies with potential treatment
The U.S. Food and Drug Administration approved Cidara Therapeutics and Melinta Therapeutics' antifungal drug for patients with little to no other options.
Moderna COVID vaccines expected to cost $130
Moderna plans to charge $130 for a single dose of its COVID vaccine, according to a recent report. That's in line with what Pfizer said it would for its version.
Moderna adding 2,000 new workers this year
Moderna will add to its workforce and its U.S. real estate footprint, the biotech company announced in a press release Friday. The employees will be added by the end of the year.
US probe of dog breeder scrutinizes why USDA left thousands of beagles to suffer
USDA took no action against drug maker Envigo who had to forfeit 4,000 beagles after mistreating them. Envigo settled civil charges but Grand Jury explores legal options.